More on ICCC
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $9.95 |
|
|||
| Open | $9.80 | ||||
| 52 Wk High | $8.29 | ||||
| 52 Wk Low | $4.99 | ||||
| Day High | $10.16 | ||||
| Day Low | $9.74 | ||||
| P/E | 126.63 | ||||
| EPS | $0.08 | ||||
| Volume | 3,184 | ||||
- Immucell Corp (ICCC) Reports Q2 EPS of $0.20
- Form 10-Q IMMUCELL CORP /DE/ For: Jun 30
- Form 8-K IMMUCELL CORP /DE/ For: Aug 13
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2026
- Form 8-K IMMUCELL CORP /DE/ For: Jul 09
- ImmuCell reports 11.5% sales rise in Q2 2026, 20.9% gain for first half
- ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
- Form 4 IMMUCELL CORP /DE/ For: Jun 18 Filed by: te Boekhorst Paul Francis Olivier
- Form 8-K IMMUCELL CORP /DE/ For: Jun 11
Entities mentioned with ICCC
- Earnings | View Related Stories »
- FDA | View Related Stories »
- S3 | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Definitive Agreement | View Related Stories »
- 13D | View Related Stories »
- Show More...
